My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice.

    Hanson BJ, Boon AC, Lim AP, Webb A, Ooi EE, Webby RJ.

    Respir Res. 2006 Oct 14;7:126.PMID: 17040574 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.

    Prabhu N, Prabakaran M, Hongliang Q, He F, Ho HT, Qiang J, Goutama M, Lim AP, Hanson BJ, Kwang J.

    Antivir Ther. 2009;14(7):911-21.PMID: 19918095 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.

    Simmons CP, Bernasconi NL, Suguitan AL, Mills K, Ward JM, Chau NV, Hien TT, Sallusto F, Ha do Q, Farrar J, de Jong MD, Lanzavecchia A, Subbarao K.

    PLoS Med. 2007 May;4(5):e178.PMID: 17535101 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.

    Prabakaran M, Prabhu N, He F, Hongliang Q, Ho HT, Qiang J, Meng T, Goutama M, Kwang J.

    PLoS One. 2009 May 22;4(5):e5672.PMID: 19478856 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes.

    Chen Y, Qin K, Wu WL, Li G, Zhang J, Du H, Ng MH, Shih JW, Peiris JS, Guan Y, Chen H, Xia N.

    J Infect Dis. 2009 Jan 1;199(1):49-58.PMID: 19032063 [PubMed - indexed for MEDLINE]Related articles

    6.

    Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

    Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.

    PLoS One. 2008;3(12):e3942. Epub 2008 Dec 16.PMID: 19079604 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.

    Prabhu N, Prabakaran M, Ho HT, Velumani S, Qiang J, Goutama M, Kwang J.

    J Virol. 2009 Mar;83(6):2553-62. Epub 2008 Dec 24.PMID: 19109379 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.

    Zheng L, Wang F, Yang Z, Chen J, Chang H, Chen Z.

    BMC Infect Dis. 2009 Feb 12;9:17.PMID: 19216752 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.

    Mayrhofer J, Coulibaly S, Hessel A, Holzer GW, Schwendinger M, Brühl P, Gerencer M, Crowe BA, Shuo S, Hong W, Tan YJ, Dietrich B, Sabarth N, Savidis-Dacho H, Kistner O, Barrett PN, Falkner FG.

    J Virol. 2009 May;83(10):5192-203. Epub 2009 Mar 11.PMID: 19279103 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.

    Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q, Belser JA, Hancock K, Shu Y, Katz JM, Liang M, Li D.

    PLoS One. 2009;4(5):e5476. Epub 2009 May 7.PMID: 19421326 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Monoclonal antibodies to highly pathogenic avian influenza A(H5N1) strain isolated in the Russian Federation: development and properties]

    Kushch AA, Klimova RR, Masalova OV, Fedorova NE, Botikov AG, Fediakina IT, Burtseva EI, Isaeva EI, Deriabin PG, L'vov DK.

    Vopr Virusol. 2008 Sep-Oct;53(5):9-14. Russian. PMID: 19069786 [PubMed - indexed for MEDLINE]Related articles

    12.

    Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.

    Lu J, Guo Z, Pan X, Wang G, Zhang D, Li Y, Tan B, Ouyang L, Yu X.

    Respir Res. 2006 Mar 23;7:43.PMID: 16553963 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

    Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H.

    J Virol. 2007 Jan;81(1):150-8. Epub 2006 Oct 18.PMID: 17050610 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir.

    Koudstaal W, Koldijk MH, Brakenhoff JP, Cornelissen LA, Weverling GJ, Friesen RH, Goudsmit J.

    J Infect Dis. 2009 Dec 15;200(12):1870-3.PMID: 19911992 [PubMed - indexed for MEDLINE]Related articles

    15.

    Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.

    Lim AP, Wong SK, Chan AH, Chan CE, Ooi EE, Hanson BJ.

    Virol J. 2008 Jul 11;5:80.PMID: 18616831 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

    Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

    Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.PMID: 17050041 [PubMed - indexed for MEDLINE]Related articles

    17.

    Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

    Kreijtz JH, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RA, Lower J, Osterhaus AD, Sutter G, Rimmelzwaan GF.

    J Infect Dis. 2007 Jun 1;195(11):1598-606. Epub 2007 Apr 17.PMID: 17471429 [PubMed - indexed for MEDLINE]Related articles

    18.

    Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.

    Garg S, Hoelscher M, Belser JA, Wang C, Jayashankar L, Guo Z, Durland RH, Katz JM, Sambhara S.

    Clin Vaccine Immunol. 2007 Jul;14(7):926-8. Epub 2007 May 9.PMID: 17494637 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.

    Forrest HL, Khalenkov AM, Govorkova EA, Kim JK, Del Giudice G, Webster RG.

    Vaccine. 2009 Jun 24;27(31):4187-95. Epub 2009 May 9.PMID: 19406182 [PubMed - indexed for MEDLINE]Related articles

    20.

    Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

    Bodewes R, Kreijtz JH, Baas C, Geelhoed-Mieras MM, de Mutsert G, van Amerongen G, van den Brand JM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

    PLoS One. 2009;4(5):e5538. Epub 2009 May 14.PMID: 19440239 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk